Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

448 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer.
Casey MC, Prakash A, Holian E, McGuire A, Kalinina O, Shalaby A, Curran C, Webber M, Callagy G, Bourke E, Kerin MJ, Brown JA. Casey MC, et al. Among authors: shalaby a. BMC Cancer. 2019 Jul 19;19(1):712. doi: 10.1186/s12885-019-5884-x. BMC Cancer. 2019. PMID: 31324173 Free PMC article.
Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways.
Garrido P, Shalaby A, Walsh EM, Keane N, Webber M, Keane MM, Sullivan FJ, Kerin MJ, Callagy G, Ryan AE, Glynn SA. Garrido P, et al. Among authors: shalaby a. Oncotarget. 2017 Jul 26;8(46):80568-80588. doi: 10.18632/oncotarget.19631. eCollection 2017 Oct 6. Oncotarget. 2017. PMID: 29113326 Free PMC article.
Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study.
O'Loughlin M, Andreu X, Bianchi S, Chemielik E, Cordoba A, Cserni G, Figueiredo P, Floris G, Foschini MP, Heikkilä P, Kulka J, Liepniece-Karele I, Regitnig P, Reiner A, Ryska A, Sapino A, Shalaby A, Stovgaard ES, Quinn C, Walsh EM, Zolota V, Glynn SA, Callagy G. O'Loughlin M, et al. Among authors: shalaby a. Breast Cancer Res Treat. 2018 Aug;171(1):1-9. doi: 10.1007/s10549-018-4825-8. Epub 2018 May 17. Breast Cancer Res Treat. 2018. PMID: 29774470
Quantifying Tip60 (Kat5) stratifies breast cancer.
McGuire A, Casey MC, Shalaby A, Kalinina O, Curran C, Webber M, Callagy G, Holian E, Bourke E, Kerin MJ, Brown JAL. McGuire A, et al. Among authors: shalaby a. Sci Rep. 2019 Mar 7;9(1):3819. doi: 10.1038/s41598-019-40221-5. Sci Rep. 2019. PMID: 30846725 Free PMC article.
Cefotaxime diffusion in the vitreous humour: a pharmacokinetic case series.
Shalaby A, Benaboud S, Dedieu D, Anjou M, Rasmussen C, Brezin A, Richebe P, Froelicher Bournaud L, Rouillon S, Guyonnet C, Poyart C, Charlier C, Canouï E. Shalaby A, et al. J Antimicrob Chemother. 2024 Jun 12:dkae195. doi: 10.1093/jac/dkae195. Online ahead of print. J Antimicrob Chemother. 2024. PMID: 38863388 No abstract available.
IDH1 inhibition potentiates chemotherapy efficacy in pancreatic cancer.
Zarei M, Hajihassani O, Hue JJ, Loftus AW, J Graor H, Nakazzi F, Naji P, Boutros CS, Uppin V, Vaziri-Gohar A, Shalaby A, Asara JM, Rothermel LD, Brody JR, Winter JM. Zarei M, et al. Among authors: shalaby a. Cancer Res. 2024 Jun 6. doi: 10.1158/0008-5472.CAN-23-1895. Online ahead of print. Cancer Res. 2024. PMID: 38843355
Dysregulation of miR-122, miR-574 and miR-375 in Egyptian patients with breast cancer.
Elghoroury EA, Abdelghafar EE, Kamel S, Awadallah E, Shalaby A, El-Saeed GSM, Mahmoud E, Kamel MM, Abobakr A, Yousef RN. Elghoroury EA, et al. Among authors: shalaby a. PLoS One. 2024 May 31;19(5):e0298536. doi: 10.1371/journal.pone.0298536. eCollection 2024. PLoS One. 2024. PMID: 38820252 Free PMC article.
448 results